logo

Blog Articles for IMGN
Investment U image
Investing In The Biotech Sector: Here’s An Easy Way To Profit From Biotech Stocks
By: Investment U
Publish Date: Wednesday, November 11, 2009
Stocks(s): ARIA, ASCO, BBI, BMRN, BMY, CELG, IMGN, JPM
Sector(s): Finance, Medical

Morningstar image
Get Instant Biotech Diversification
By: Morningstar
Publish Date: Thursday, October 22, 2009
Stocks(s): , AMGN, BBH, BBI, GENZ, IBB, IMGN, PBE
Sector(s): Medical

Ohad Hammer image
The Clock Is Ticking On Micromet (MITI)
By: Ohad Hammer
Publish Date: Monday, August 24, 2009
Stocks(s): AZN, BMY, EXEL, IMGN, MITI, RBC, SGEN, SNY
Sector(s): Medical

Ohad Hammer image
Curagen (NasdaqGM: CRGN)– Positive Results At ASCO 2009
By: Ohad Hammer
Publish Date: Tuesday, July 07, 2009
Stocks(s): CLDX, CRGN, IMGN, RHHBY.PK, SGEN
Sector(s): Medical

TheStockAdvisors.com image
Immunogen (Nasdaq: IMGN): Antibody Play
By: TheStockAdvisors.com
Publish Date: Wednesday, July 01, 2009
Stocks(s): IMGN
Sector(s): Medical

Ohad Hammer image
Top Picks For ASCO 2009
By: Ohad Hammer
Publish Date: Tuesday, May 26, 2009
Stocks(s): ARIA, ARQL, ASCO, BMY, CEPH, CRGN, EXEL, IMGN
Sector(s): Medical

Mike Havrilla image
FDA, Clinical Trial Calendar Updates
By: Mike Havrilla
Publish Date: Monday, May 11, 2009
Stocks(s): AZN, IMGN, MELA, MIPI
Sector(s): Medical

Ohad Hammer image
Good News For Roche, Excellent News For Immunogen
By: Ohad Hammer
Publish Date: Friday, March 20, 2009
Stocks(s): DNA, IMGN
Sector(s): Medical

Ohad Hammer image
Immunogen and Exelixis Defy the Myth of Recession
By: Ohad Hammer
Publish Date: Saturday, December 20, 2008
Stocks(s): ARQL, BMY, DNA, EXEL, GSK, IMGN, NVS, RIGL
Sector(s): Medical

Ohad Hammer image
Biotech Portfolio Updates- Buying More Immunogen
By: Ohad Hammer
Publish Date: Thursday, October 16, 2008
Stocks(s): BMY, DNA, IMGN
Sector(s): Medical, Personal Finance

Ohad Hammer image
Immunogen – Lost In Translation
By: Ohad Hammer
Publish Date: Wednesday, October 15, 2008
Stocks(s): DNA, IMGN
Sector(s): Medical

Ohad Hammer image
When There Is Blood In The Streets - Buy Biotech
By: Ohad Hammer
Publish Date: Friday, October 10, 2008
Stocks(s): AMGN, ARQL, ARRY, BBI, DNA, EXEL, GILD, IMGN
Sector(s): Medical

TheStockAdvisors.com image
Immunogen: The Time Has Come
By: TheStockAdvisors.com
Publish Date: Tuesday, September 23, 2008
Stocks(s): DNA, IMGN
Sector(s): Medical

Ohad Hammer image
Exelixis as a Platform Company
By: Ohad Hammer
Publish Date: Wednesday, September 03, 2008
Stocks(s): EXEL, IMGN, ISIS, SGEN
Sector(s): Medical

Ohad Hammer image
Another Seal of Approval For Micromet
By: Ohad Hammer
Publish Date: Tuesday, August 19, 2008
Stocks(s): AZN, CLDA, IMGN, MEDI, MITI, SNY
Sector(s): Medical

Ohad Hammer image
Genentech’s Shiny New Platform
By: Ohad Hammer
Publish Date: Wednesday, August 06, 2008
Stocks(s): ADC, DNA, IMGN, SGEN
Sector(s): Finance, Medical

Ohad Hammer image
Immunogen at ASCO Annual Meeting 2008
By: Ohad Hammer
Publish Date: Tuesday, July 15, 2008
Stocks(s): ASCO, CRGN, DNA, IMGN, SGEN, SNTA, SNY
Sector(s): Medical

Ohad Hammer image
Immunogen and Seattle Genetics – On The Verge Of An Inflection Point
By: Ohad Hammer
Publish Date: Saturday, May 24, 2008
Stocks(s): ADC, ASCO, CLDA, CRGN, DNA, IMGN, MITI, SGEN
Sector(s): Finance, Medical

Ohad Hammer image
Micromet - Biting Cancer (Part I)
By: Ohad Hammer
Publish Date: Tuesday, January 29, 2008
Stocks(s): ADC, CEGE, GNSY, GSK, IMGN, MITI, SGEN
Sector(s): Finance, Medical

Page 1 of 1
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia